Pharmacological options in the treatment of benign prostatic hyperplasia

被引:162
作者
Kenny, B [1 ]
Ballard, S [1 ]
Blagg, J [1 ]
Fox, D [1 ]
机构
[1] PFIZER LTD,CENT RES,DEPT DISCOVERY CHEM,SANDWICH CT13 9NJ,KENT,ENGLAND
关键词
D O I
10.1021/jm960697s
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:1293 / 1315
页数:23
相关论文
共 156 条
[1]  
ABELL AD, 1995, CURR MED CHEM, V2, P583
[2]   A NONSTEROIDAL DIENE ACID INHIBITOR OF HUMAN TYPE-2 STEROID 5-ALPHA-REDUCTASE [J].
ABELL, AD ;
BRANDT, M ;
LEVY, MA ;
HOLT, DA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (19) :2327-2330
[3]   CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY [J].
ANDERSEN, JT ;
EKMAN, P ;
WOLF, H ;
BEISLAND, HO ;
JOHANSSON, JE ;
KONTTURI, M ;
LEHTONEN, T ;
TVETER, K ;
BODKER, A ;
VEDEL, O ;
NORDLING, J ;
POULSEN, AL ;
SCHOU, J ;
HVIDT, V ;
HANSEN, JB ;
MEYHOFF, HH ;
ELDRUP, J ;
HARTWELL, D ;
COLSTRUP, H ;
LYNGDORF, P ;
NIELSEN, AH ;
LARSEN, E ;
WALTER, S ;
LARSEN, EH ;
THYBO, E ;
MOMMSEN, S ;
BROK, KE ;
PALM, L ;
GENSTER, H ;
ANDERSEN, M ;
KAUPPINEN, P ;
RAUVALA, M ;
HAKKINEN, J ;
TAMMELA, T ;
TAINIO, H ;
HYNNINEN, O ;
TIITINEN, J ;
LEHTORANTA, K ;
ALAOPAS, M ;
PERTTILA, I ;
PETAS, A ;
RINTALA, E ;
SALMINEN, R ;
JUUSELA, H ;
HANSSON, E ;
VONWENDT, R ;
TUHKANEN, K ;
TALJA, M ;
NURMI, M ;
PUNTALA, P .
UROLOGY, 1995, 46 (05) :631-637
[4]   DELETION OF STEROID 5-ALPHA-REDUCTASE 2-GENE IN MALE PSEUDOHERMAPHRODITISM [J].
ANDERSSON, S ;
BERMAN, DM ;
JENKINS, EP ;
RUSSELL, DW .
NATURE, 1991, 354 (6349) :159-161
[5]  
ANDERSSON S, 1990, P NATL ACAD SCI USA, V87, P8640
[6]  
ANDERSSON S, 1991, Patent No. 17251
[7]  
ANDREWS RC, 1996, Patent No. 16049
[8]   SYNTHESIS AND HYPOTENSIVE ACTIVITY OF BENZAMIDOPIPERIDYLETHYLINDOLES [J].
ARCHIBALD, JL ;
ALPS, BJ ;
CAVALLA, JF ;
JACKSON, JL .
JOURNAL OF MEDICINAL CHEMISTRY, 1971, 14 (11) :1054-+
[9]  
AUDET P, 1993, CLIN PHARMACOL THER, V53, P231
[10]   4-AZA-3-OXO-5-ALPHA-ANDROST-1-ENE-17-BETA-N-ARYL-CARBOXAMIDES AS DUAL INHIBITORS OF HUMAN TYPE-1 AND TYPE-2 STEROID 5-ALPHA-REDUCTASES - DRAMATIC EFFECT OF N-ARYL SUBSTITUENTS ON TYPE-1 AND TYPE-2 5-ALPHA-REDUCTASE INHIBITORY POTENCY [J].
BAKSHI, RK ;
RASMUSSON, GH ;
PATEL, GF ;
MOSLEY, RT ;
CHANG, B ;
ELLSWORTH, K ;
HARRIS, GS ;
TOLMAN, RL .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) :3189-3192